A historic shift in Canadian drug policy has occurred, as the government allow the legalization of psilocybin hallucinogens for therapeutic purposes. Previously, these substances were heavily restricted, but a mounting body of evidence suggests they potentially offer benefits for emotional issues like depression. This development represents a key s